Abstract
BackgroundFollowing the extensive use of immunosuppressive drugs in the clinic, immunosuppression-associated side effects have received increasing attention. Epstein-Barr virus (EBV) reactivation and related lymphoproliferative diseases (LPD) are the lethal complications...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have